The legacy of back room wheelin’ and dealin’ by the drug industry, which routinely pays off doctors and academic researchers to hawk oftentimes dangerous and ineffective pharmaceuticals and medical devices, could soon be blown wide open by newly enacted legislation passed as part of the Affordable Care Act of 2010.
The Physician Payments Sunshine Act, which was successfully moved through the Senate with the help of an extensive investigation led by Senator Charles Grassley (R-IA), provisions that doctors who receive payoffs from drug or vaccine companies must disclose this when pushing new therapies or medical procedures from what would otherwise appear to be unbiased intentions.
The law was reportedly added to Obamacare because it was unlikely to pass on its own due to intense industry pressures against any sort of reform. Paying off doctors has become the bread and butter of Big Pharma drug marketing. It’s both discreet and highly effective, repeatedly creating the illusion that the medical profession at large endorses the latest drugs and medical procedures, many of which aren’t safe and don’t work.